EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
| MEGHAN O'BRIEN | — |
Medicare/Medicaid MMM
CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
| MEGHAN O'BRIEN | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
Trade (domestic/foreign) TRD
Supply Chain Proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.